Categories: STL.News

GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer

Chalfont St Giles, UK (STL.News) – GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent. Theragnostics will lead…

The post GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer appeared first on STL.News.

Source link

Share

Recent Posts

GE to Sell Lighting Business to Savant Systems, Inc.

Deal will create an industry leader combining GE’s brand, lighting expertise and retailer channels with…

47 mins ago

Predictions for a Severe 2020 Hurricane Season

Predictions for a Severe 2020 Hurricane Season Drive Need for Disaster Preparedness by Public Safety…

2 hours ago

Apache Corporation Announces Exclusive Listing on NASDAQ

HOUSTON, TX (STL.News) Apache Corporation (NYSE, Nasdaq: APA) today announced it has elected to list…

3 hours ago

United Turns Old Uniforms Into Masks for Employees

CHICAGO, IL (STL.News) United Airlines delivered 7,500 face coverings over the past week to front…

4 hours ago

Boeing Resumes 737 MAX Production

Production system enhanced through factory initiatives RENTON, WA (STL.News) Boeing [NYSE: BA] has resumed production…

5 hours ago

Nephrology Practice Solutions Names Dr. Thao Truong Pascual as New Chief Medical Officer

Dr. Thao Truong Pascual has assumed the clinical leadership role for DaVita’s growing nephrology practice…

6 hours ago